Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer.

P A Vasey; H Roché; D Bisset; C Terret; L Vernillet; A Riva; C Ramazeilles; N Azli; S B Kaye; C J Twelves

doi:10.1038/sj.bjc.6600626

Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer.

Identifier:nobleid.org/w1/20260515/70BDFEEF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/70BDFEEF.svg?ark=w1%2F20260515%2F70BDFEEF)](https://nobleid.org/work/w1/20260515/70BDFEEF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer.

Identifier:nobleid.org/w1/20260515/70BDFEEF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/70BDFEEF.svg?ark=w1%2F20260515%2F70BDFEEF)](https://nobleid.org/work/w1/20260515/70BDFEEF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work